The relationship between the pharmacogenetics and pharmacokinetics of CFTR modulators in a population of children with cystic fibrosis
The triple combination of elexacaftor / tezacaftor / ivacaftor is one of the key tools for targeted pharmacotherapy of cystic fibrosis. In the pediatric population, its use may be accompanied by a variable therapeutic response, which may be due to age-related pharmacokinetic features, as well as the...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Russo |
| Publicat: |
Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute
2026-07-01
|
| Col·lecció: | Фармация и фармакология (Пятигорск) |
| Matèries: | |
| Accés en línia: | https://www.pharmpharm.ru/jour/article/view/1921 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|